SEC Form 4 · accession 0001127602-16-050444
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine Sazdanoff
Director
Period of report
Apr 29, 2016
Accepted (ET)
May 2, 2016 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 29, 2016 | P | 7,700 | $19.2005 | A | 7,700 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Prices range from $19.02 per share to $19.39 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.